Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
27.37
-0.31 (-1.12%)
At close: Apr 24, 2026, 4:00 PM EDT
26.99
-0.38 (-1.39%)
After-hours: Apr 24, 2026, 7:56 PM EDT
Catalyst Pharmaceuticals Market Cap
Catalyst Pharmaceuticals has a market cap or net worth of $3.34 billion as of April 24, 2026. Its market cap has increased by 21.03% in one year.
Market Cap
3.34B
Enterprise Value
2.64B
1-Year Change
21.03%
Ranking
Category
Stock Price
$27.37
Market Cap Chart
Since November 8, 2006, Catalyst Pharmaceuticals's market cap has increased from $76.40M to $3.34B, an increase of 4,275.04%. That is a compound annual growth rate of 21.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 3.34B | 16.51% |
| Dec 31, 2025 | 2.87B | 15.25% |
| Dec 31, 2024 | 2.49B | 38.90% |
| Dec 29, 2023 | 1.79B | -7.42% |
| Dec 30, 2022 | 1.94B | 177.28% |
| Dec 31, 2021 | 698.10M | 101.65% |
| Dec 31, 2020 | 346.20M | -10.40% |
| Dec 31, 2019 | 386.40M | 95.84% |
| Dec 31, 2018 | 197.30M | -40.80% |
| Dec 29, 2017 | 333.30M | 283.10% |
| Dec 30, 2016 | 87.00M | -57.12% |
| Dec 31, 2015 | 202.90M | -1.17% |
| Dec 31, 2014 | 205.30M | 94.41% |
| Dec 31, 2013 | 105.60M | 599.34% |
| Dec 31, 2012 | 15.10M | -52.66% |
| Dec 30, 2011 | 31.90M | 66.15% |
| Dec 31, 2010 | 19.20M | 68.42% |
| Dec 31, 2009 | 11.40M | -54.94% |
| Dec 31, 2008 | 25.30M | -41.44% |
| Dec 31, 2007 | 43.20M | -28.60% |
| Dec 29, 2006 | 60.50M | -20.81% |
| Nov 8, 2006 | 76.40M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 3.72B |
| Telix Pharmaceuticals | 3.61B |
| Oruka Therapeutics | 3.47B |
| NewAmsterdam Pharma Company | 3.42B |
| Edgewise Therapeutics | 3.39B |
| Structure Therapeutics | 3.22B |
| Arcus Biosciences | 3.20B |
| Alumis | 3.17B |